JP2020530478A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020530478A5 JP2020530478A5 JP2020508049A JP2020508049A JP2020530478A5 JP 2020530478 A5 JP2020530478 A5 JP 2020530478A5 JP 2020508049 A JP2020508049 A JP 2020508049A JP 2020508049 A JP2020508049 A JP 2020508049A JP 2020530478 A5 JP2020530478 A5 JP 2020530478A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- seq
- uspa2
- pila
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023080924A JP2023103380A (ja) | 2017-08-14 | 2023-05-16 | 免疫応答を強化する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762545010P | 2017-08-14 | 2017-08-14 | |
| US62/545,010 | 2017-08-14 | ||
| US201862633263P | 2018-02-21 | 2018-02-21 | |
| US62/633,263 | 2018-02-21 | ||
| PCT/EP2018/071860 WO2019034575A1 (en) | 2017-08-14 | 2018-08-13 | Methods of boosting immune responses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023080924A Division JP2023103380A (ja) | 2017-08-14 | 2023-05-16 | 免疫応答を強化する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020530478A JP2020530478A (ja) | 2020-10-22 |
| JP2020530478A5 true JP2020530478A5 (enExample) | 2021-08-26 |
Family
ID=63350516
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020508049A Pending JP2020530478A (ja) | 2017-08-14 | 2018-08-13 | 免疫応答を強化する方法 |
| JP2023080924A Pending JP2023103380A (ja) | 2017-08-14 | 2023-05-16 | 免疫応答を強化する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023080924A Pending JP2023103380A (ja) | 2017-08-14 | 2023-05-16 | 免疫応答を強化する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11723966B2 (enExample) |
| EP (1) | EP3641808A1 (enExample) |
| JP (2) | JP2020530478A (enExample) |
| CN (1) | CN110996994A (enExample) |
| BR (1) | BR112020001768A2 (enExample) |
| CA (1) | CA3072018A1 (enExample) |
| MX (1) | MX2020001820A (enExample) |
| WO (1) | WO2019034575A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022543264A (ja) * | 2019-08-05 | 2022-10-11 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | プロテインｄポリペプチドを含む組成物を調製するプロセス |
| EP4294433A1 (en) * | 2021-02-22 | 2023-12-27 | GlaxoSmithKline Biologicals SA | Immunogenic composition, use and methods |
| WO2023194971A2 (en) * | 2022-04-08 | 2023-10-12 | St. Jude Children's Research Hospital | Immunogenic compositions and methods for reducing transmission of pathogens |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| SE466259B (sv) * | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| DE69313134T2 (de) | 1992-06-25 | 1998-02-26 | Smithkline Beecham Biolog | Adjuvantien enthaltende impfstoffzusammensetzung |
| KR100310510B1 (ko) | 1993-03-23 | 2002-07-04 | 장 스테판느 | 3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물 |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| AU713040B2 (en) | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| DE69740108D1 (de) * | 1996-12-20 | 2011-03-10 | Univ Texas | Moraxella catarrhalis antigene uspa1 und uspa2 |
| CA2366152A1 (en) | 1999-03-19 | 2000-09-28 | Smithkline Beecham Biologicals S.A. | Streptococcus pneumoniae vaccine |
| EP2292632A3 (en) | 2000-09-26 | 2012-07-25 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| WO2003035836A2 (en) | 2001-10-24 | 2003-05-01 | Hybridon Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| WO2007018463A2 (en) * | 2005-08-10 | 2007-02-15 | Arne Forsgren Ab | Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| MX2008009280A (es) | 2006-01-17 | 2008-12-12 | Arne Forsgren | Una nueva proteina de haemophilus influenzae expuesta en la superficie (proteina e; pe). |
| TW201302779A (zh) | 2011-04-13 | 2013-01-16 | Glaxosmithkline Biolog Sa | 融合蛋白質及組合疫苗 |
| TW201620927A (zh) | 2014-02-24 | 2016-06-16 | 葛蘭素史密斯克藍生物品公司 | Ｕｓｐａ２蛋白質構築體及其用途 |
-
2018
- 2018-08-13 JP JP2020508049A patent/JP2020530478A/ja active Pending
- 2018-08-13 BR BR112020001768-0A patent/BR112020001768A2/pt not_active IP Right Cessation
- 2018-08-13 CN CN201880052580.5A patent/CN110996994A/zh active Pending
- 2018-08-13 US US16/638,595 patent/US11723966B2/en active Active
- 2018-08-13 CA CA3072018A patent/CA3072018A1/en active Pending
- 2018-08-13 MX MX2020001820A patent/MX2020001820A/es unknown
- 2018-08-13 WO PCT/EP2018/071860 patent/WO2019034575A1/en not_active Ceased
- 2018-08-13 EP EP18759058.3A patent/EP3641808A1/en active Pending
-
2023
- 2023-05-16 JP JP2023080924A patent/JP2023103380A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1674933B (zh) | 疫苗组合物 | |
| CN116023510B (zh) | 双佐剂重组带状疱疹疫苗 | |
| JP2008530245A5 (enExample) | ||
| KR20210093854A (ko) | 다가 폐렴구균 백신 | |
| Yang et al. | Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization | |
| US6558673B1 (en) | Complexes of immunogens derived from RSV surface glycoprotein G covalently coupled to a support molecule | |
| JP2010500399A5 (enExample) | ||
| CN1635904A (zh) | 肺炎链球菌疫苗 | |
| JP2006504653A5 (enExample) | ||
| JP4238031B2 (ja) | ワクチン | |
| RU2007145052A (ru) | Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера | |
| JP2015536134A5 (enExample) | ||
| JP2003500040A5 (enExample) | ||
| CN111961138A (zh) | 疫苗融合蛋白 | |
| JP2009520758A5 (enExample) | ||
| JP2023052092A (ja) | 免疫原性組成物 | |
| JP2002543098A (ja) | Ｉｌ５活性のダウン−レギュレート方法 | |
| JP2009500037A5 (enExample) | ||
| JP2023103380A (ja) | 免疫応答を強化する方法 | |
| US9119803B2 (en) | Carious tooth vaccine and preparation method | |
| US20180078636A1 (en) | Hepatitis b therapeutic vaccines | |
| US20210322544A1 (en) | Vaccine composition comprising hepatitis b virus-like particle as adjuvant | |
| US20200172587A1 (en) | Hydrochloride salts of c5a receptor agonist peptides | |
| CN105198982B (zh) | 基于il-6的抗原表位及其应用 | |
| JP5906019B2 (ja) | 免疫刺激ｇ９．１の抗結核ブースターワクチン創出への応用 |